Crabel Capital Management’s Intersect ENT, Inc XENT Stock Holding History

Crabel Capital Management’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-273,423	Closed	-$7.66M	–	112
2022 Q1	$7.66M	Hold	273,423	–	–	2.37%	9
2021 Q4	$7.47M	Hold	273,423	–	–	1.34%	32
2021 Q3	$7.44M	Buy	+273,423	New	+$6.76M	2.29%	13

Crabel Capital Management's XENT Position: Q2 2022 in Review

Crabel Capital Management sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 273,423 shares — an estimated $7.66M sold.

Crabel Capital Management first reported a position in XENT in Q3 2021 and held it in 3 quarters. The position peaked at $7.66M in Q1 2022. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

Crabel Capital Management reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
Crabel Capital Management sold 273,423 Intersect ENT, Inc shares in Q2 2022, an estimated $7.66M.
Crabel Capital Management first reported a position in Intersect ENT, Inc in Q3 2021 and held it in 3 quarters.
Crabel Capital Management's Intersect ENT, Inc position peaked at $7.66M in Q1 2022.
0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Crabel Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.